"Treat Only the Cancer & Preserve Quality of Life"
"Treat Only the Cancer & Preserve Quality of Life"
Professor of Surgery/Urology
Professor of Surgery/Urology
Director of the Prostate Cancer Fellowship Program
Director of the Prostate Cancer Fellowship Program
University of Colorado Denver School of Medicine
University of Colorado Denver School of Medicine
12631 East 17th Ave., Room L15-5602,
Academic Office One Bldg. MS C-319
Aurora, CO 80045
clinic: 720-848-1800
office: 303-724-2722
fax: 303-724-2818
-------------------------------------------
-------------------------------------------
Dr. Barqawi performed the first focal stereotactic interstitial laser treatment of prostate cancer guided by MRI thermal imaging
Dr. Barqawi performed the first focal stereotactic interstitial laser treatment of prostate cancer guided by MRI thermal imaging
Dr. Barqawi also conducted the first trial in the US using (Botox) injections for the treatment of BPH (Enlarged Prostate) related lower urinary symptoms
Dr. Barqawi also conducted the first trial in the US using (Botox) injections for the treatment of BPH (Enlarged Prostate) related lower urinary symptoms
Dr. Barqawi performed more than a thousand cryotherapy procedures to treat prostate cancer with excellent results
Dr. Barqawi performed more than a thousand cryotherapy procedures to treat prostate cancer with excellent results
The Facts
The Facts
Prostate Cancer affects more than a quarter million men in the USA every year.
Prostate Cancer affects more than a quarter million men in the USA every year.
One out of ten of these men will die from prostate cancer.
One out of ten of these men will die from prostate cancer.
Widespread screening has been cited to cause over diagnosis of the disease.
Widespread screening has been cited to cause over diagnosis of the disease.
The majority of these men will survive the disease regardless of treatment.
The majority of these men will survive the disease regardless of treatment.
The Challenges
The Challenges
The treatment options available for early stage organ-confined and low risk prostate cancer have been controversial.
The treatment options available for early stage organ-confined and low risk prostate cancer have been controversial.
A substantial number of men diagnosed with prostate cancer are over treated.
A substantial number of men diagnosed with prostate cancer are over treated.
The current treatment options; including radical prostatectomy and radiation therapy are associated with significant long term side effects.
The current treatment options; including radical prostatectomy and radiation therapy are associated with significant long term side effects.